Compositions, vaccines and kits for cancer immunotherapy are described.
The compositions, vaccines and kits may include transfer factor. The
compositions, vaccines and kits also include modified monoclonal
antibodies directed to cancer cells, other specific cancer receptor
agonists, or viruses which infect cancer cells. The invention is also
directed to methods of cancer immunotherapy using the compositions and
vaccines of the invention.